| Literature DB >> 31043574 |
Atsushi Aoyagi1,2, Carlo Condello3,4, Jan Stöhr1,4,5, Weizhou Yue1, Brianna M Rivera1, Joanne C Lee1, Amanda L Woerman1,4, Glenda Halliday6, Sjoerd van Duinen7, Martin Ingelsson8, Lars Lannfelt8, Caroline Graff9,10, Thomas D Bird11,12, C Dirk Keene13, William W Seeley4,14, William F DeGrado1,15, Stanley B Prusiner3,4,16.
Abstract
The hallmarks of Alzheimer's disease (AD) are the accumulation of Aβ plaques and neurofibrillary tangles composed of hyperphosphorylated tau. We developed sensitive cellular assays using human embryonic kidney-293T cells to quantify intracellular self-propagating conformers of Aβ in brain samples from patients with AD or other neurodegenerative diseases. Postmortem brain tissue from patients with AD had measurable amounts of pathological Aβ conformers. Individuals over 80 years of age had the lowest amounts of prion-like Aβ and phosphorylated tau. Unexpectedly, the longevity-dependent decrease in self-propagating tau conformers occurred in spite of increasing amounts of total insoluble tau. When corrected for the abundance of insoluble tau, the ability of postmortem AD brain homogenates to induce misfolded tau in the cellular assays showed an exponential decrease with longevity, with a half-life of about one decade over the age range of 37 to 99 years. Thus, our findings demonstrate an inverse correlation between longevity in patients with AD and the abundance of pathological tau conformers. Our cellular assays can be applied to patient selection for clinical studies and the development of new drugs and diagnostics for AD.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31043574 PMCID: PMC6640844 DOI: 10.1126/scitranslmed.aat8462
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956